|Bid||0.0000 x 3100|
|Ask||0.0000 x 2900|
|Day's range||3.7600 - 4.1000|
|52-week range||2.7700 - 5.7400|
|Beta (5Y monthly)||1.26|
|PE ratio (TTM)||N/A|
|Earnings date||03 Nov 2021 - 08 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||9.10|
Chiasma, Inc. ( NASDAQ:CHMA ) is possibly approaching a major achievement in its business, so we would like to shine...
Chiasma (CHMA) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Chiasma, Inc. (NasdaqGS: CHMA) to Amryt (NasdaqGS: AMYT). Under the terms of the proposed transaction, shareholders of Chiasma will receive 0.396 American Depositary Shares of Amryt for each share of Chiasma that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.